These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10968816)

  • 1. Drug points: prolonged cholestasis associated with irbesartan.
    Hariraj R; Stoner E; Jader S; Preston DM
    BMJ; 2000 Sep; 321(7260):547. PubMed ID: 10968816
    [No Abstract]   [Full Text] [Related]  

  • 2. Could irbesartan trigger autoimmune cholestatic hepatitis?
    Annicchiarico BE; Siciliano M
    Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):247-8. PubMed ID: 15674105
    [No Abstract]   [Full Text] [Related]  

  • 3. Candesartan cilexetil-induced severe hepatotoxicity.
    Basile G; Villari D; Gangemi S; Ferrara T; Accetta MG; Nicita-Mauro V
    J Clin Gastroenterol; 2003 Mar; 36(3):273-5. PubMed ID: 12590242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Irbesartan-induced acute hepatitis].
    Foruny Olcina JR; Moreira Vicente VF; Gómez García M; Morell Hita JL
    Gastroenterol Hepatol; 2004 Feb; 27(2):71-2. PubMed ID: 14733885
    [No Abstract]   [Full Text] [Related]  

  • 5. [Irbesartan induced acute hepatitis: one case].
    Péron JM; Robic MA; Bureau C; Vinel JP
    Gastroenterol Clin Biol; 2005; 29(6-7):747-8. PubMed ID: 16149188
    [No Abstract]   [Full Text] [Related]  

  • 6. [Angioedema due to irbesartan].
    Rodríguez Conesa A; Matilla Fernández B; Gozalo Reques F
    Rev Esp Cardiol; 2001 Apr; 54(4):532. PubMed ID: 11282063
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute renal failure associated with irbesartan].
    Anglada Pintado JC; Gallego Puerto P; Zapata López A; Cayón Blanco M
    Med Clin (Barc); 1999 Sep; 113(9):358-9. PubMed ID: 10562934
    [No Abstract]   [Full Text] [Related]  

  • 8. Irbesartan-associated persistent edema of the eyelids, face, and neck.
    Cohen PR
    J Drugs Dermatol; 2002 Dec; 1(3):329-30. PubMed ID: 12851994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lichenoid drug eruption due to an antihypertonic drug containing irbesartan and hydrochlorothiazide.
    Pfab F; Athanasiadis GI; Kollmar A; Ring J; Ollert M
    Allergy; 2006 Jun; 61(6):786-7. PubMed ID: 16677251
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute oliguric renal failure associated with angiotensin II receptor antagonists.
    Lee HY; Kim CH
    Am J Med; 2001 Aug; 111(2):162-3. PubMed ID: 11501548
    [No Abstract]   [Full Text] [Related]  

  • 11. Anaemia in dialysis patients as a side-effect of sartanes.
    Schwarzbeck A; Wittenmeier KW; Hällfritzsch U
    Lancet; 1998 Jul; 352(9124):286. PubMed ID: 9690412
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversion from migraine without aura to typical aura without headache after irbesartan.
    Pinessi L; Ferrero M; Gentile S; Rainero I
    J Headache Pain; 2005 Apr; 6(2):100. PubMed ID: 16362652
    [No Abstract]   [Full Text] [Related]  

  • 13. [Candesartan Cilexetil (Atacand) induced prolonged severe cholestasis improved by extracorporeal albumin dialysis].
    Sturm N; Hilleret MN; Dreyfus T; Barnoud D; Leroy V; Zarski JP
    Gastroenterol Clin Biol; 2005 Dec; 29(12):1299-301. PubMed ID: 16518295
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the efficacy and safety of irbesartan and olmesartan in patients with hypertension (EARTH study).
    Morii J; Miura S; Shiga Y; Sugihara M; Arimura T; Sako H; Zhang B; Uehara Y; Saku K
    Clin Exp Hypertens; 2012; 34(5):342-9. PubMed ID: 22568596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory hypotension after induction of anesthesia in a patient chronically treated with angiotensin receptor antagonists.
    Brabant SM; Eyraud D; Bertrand M; Coriat P
    Anesth Analg; 1999 Oct; 89(4):887-8. PubMed ID: 10512259
    [No Abstract]   [Full Text] [Related]  

  • 16. [Irbesartan].
    Caballero E; Sádaba B; Azanza JR; Honorato J
    Rev Med Univ Navarra; 1998; 42(3):166-9. PubMed ID: 10420939
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholestatic hepatitis related to use of irbesartan: a case report and a literature review of angiotensin II antagonist-associated hepatotoxicity.
    Andrade RJ; Lucena MI; Fernández MC; Vega JL; García-Cortés M; Casado M; Guerrero-Sanchez E; Pulido-Fernandez F
    Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):887-90. PubMed ID: 12172412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible losartan-induced rash.
    Haddad AM; Scholer SG
    Am J Health Syst Pharm; 1997 Jun; 54(11):1333-4. PubMed ID: 9179355
    [No Abstract]   [Full Text] [Related]  

  • 19. Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trial.
    Lewin AJ; Weir MR
    Clin Ther; 2008 Dec; 30(12):2354-65. PubMed ID: 19167594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G;
    Clin Ther; 2012 Aug; 34(8):1720-34.e3. PubMed ID: 22853847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.